ライフサイエンスコーパス: numbness

1 No partners reported penile numbness.

2 cation, photophobia, visual disturbance, and numbness.

3 d with acute-onset, right-sided weakness and numbness.

4 d with acute-onset, right-sided weakness and numbness.

5 n-years (206 for hand numbness, 187 for feet numbness, 130 for nocturia, and 127 for urgency).

6 ften reported tingling (29% v 8%; P = .001), numbness (17% v 5%; P = .005), and aching or burning pai

7 computed in 1000 person-years (206 for hand numbness, 187 for feet numbness, 130 for nocturia, and 1

8 reported less difficulty related to residual numbness and decreased lip sensitivity than those who pe

9 ic patient presented with a 7-day history of numbness and dizziness.

10 ncreased functional complaints, particularly numbness and nausea.

11 s after chemotherapy presented with the most numbness and pain and also the most pronounced sensory d

12 Sensory abnormalities such as numbness and paresthesias are often the earliest symptom

13 ing was the most severe symptom, followed by numbness and then pain.

14 Numbness and tingling are more prominent chronic neuropa

15 continued foot discomfort (eg, moderate foot numbness and tingling for 22.1% FLOX v 4.6% FULV).

16 Those reporting a numbness and tingling severity score of 3 or greater for

17 Of the sensory neuropathy symptoms, numbness and tingling were more prominent than was shoot

18 nalogue scale (VAS) assessments for "pain," "numbness," and "groin discomfort" on a scale of 0 = best

19 The symptoms of chronic pain, tingling, and numbness are generally attributed to small fiber dysfunc

20 fatigue (31.4%), insomnia (23.3%), and local numbness at the site of surgery (22.1%) occurring with g

21 diotherapy group reported severe tingling or numbness compared with 11 (6%) of 170 patients in the ra

22 dyspnea, constipation, thirst, leg swelling, numbness, dry mouth, and balance problems.

23 e events following exposure, and feelings of numbness following exposure are useful predictors of sub

24 well tolerated and reduces the rate of pain/numbness/groin discomfort by 45% relative to sutures wit

25 n reduce the incidence of postoperative pain/numbness/groin discomfort by up to 50% compared with sut

26 abling complications (VAS score >30 for pain/numbness/groin discomfort) at 12 months after surgery.

27 isaster, and those who experienced emotional numbness immediately after the disaster.

28 ingling or weakness in the arms or legs, and numbness in any part of the body correlated with appropr

29 neuropathy (CIPN), characterized by pain and numbness in hands and feet, is a common side effect of c

30 The next day, he experienced numbness in his left arm.

31 In addition, he experiences episodic numbness in his limbs, which started at the age of 37 ye

32 All had numbness in the distribution of neurectomy without compl

33 tion of this procedure was mild medial thigh numbness in two patients.

34 enced by 27 patients; 'prickling' or 'asleep numbness' in 20, mild pain in 13 and sensory loss in 23.

35 The most common long-term symptom was numbness involving the upper, inner aspect of the affect

36 A 45-year-old woman noted foot numbness, limb weakness, gait and postural instability,

37 tive arm swelling, rate of seroma formation, numbness, loss of sensitivity to light touch and pinpric

38 zed by ataxia, skeletal muscles weakness and numbness of the extremities in exposed human and laborat

39 rectly identified sudden 1-sided weakness or numbness of the face or a limb as a warning sign compare

40 One hundred fifty-three (76.5%) patients had numbness or paresthesias of the medial arm and/or axilla

41 uth, lips, or gums; trouble with eyes; pain, numbness, or tingling of hands or feet; and diarrhea or

42 ry leads to significant morbidity, including numbness, pain, weakness or paralysis.

43 disturbance of the hands and feet including numbness, paraesthesia and chronic pain.

44 LIHR has a reduced risk of chronic pain and numbness relative to OIHR.

45 , 95% CI = 0.51-0.87, P = 0.003) and chronic numbness (RR = 0.27, 95% CI = 0.12-0.58, P < 0.001) rela

46 Patients with complaints of numbness, tingling, and dysesthesias in the toes and fee

47 greater burden of neurologic symptoms (pain, numbness, tingling, and walking disability) and worse qu

48 Among chronic functional problems, numbness, tinnitus, nausea elicited by reminders of chem

49 emic or ocular signs and symptoms (headache, numbness, weakness, vertigo, syncope, diplopia, hypotens